Genmab and Incyte Plan Phase 1/2 Trial for KRAS-Mutated Metastatic Colorectal Cancer

The study will combine petosemtamab and INCB161734 with chemotherapy as a potential first-line treatment.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.